Contineum Therapeutics, Inc. CTNM
9.99 USD -0.79 (-7.29%)
Nov 12, 2026, 1:26 PM EST
9.93 Day range 10.89
6.73 52-week range 17.79
- YTD
- -12.64%
- 1 year
- -12.95%
CTNM revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | -50,000,000 | -100.00% |
| FY 2023 | 2023-12-31 | 50,000,000 | 50,000,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-01T06:01:09.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.